Ftaxilide
Based on 1 publication(s) in Google Scholar
Ftaxilide is an anti-ulcer agent. Ftaxilide exhibits notable biological properties, including antibacterial, antioxidant, and anti-tuberculosis activities. Ftaxilide shows weak binding to the Mycobacterium tuberculosis target protein (PDB ID: 1GTV). Ftaxilide can be used in research on irritable bowel syndrome and tuberculosis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98.94%
- CAS No.: 19368-18-4
- Formule: C16H15NO3
- Masse moléculaire:269.30
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Protocole
- Pureté et documentation
- Références
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Ftaxilide
More
Activité biologique
Description
In Vitro
Ftaxilide (0.5-32 µg/mL; 16 days) alone lacks significant anti-mycobacterial activity against Mycobacterium tuberculosis in the MGIT 960 assay[2].
Ftaxilide (0.1-5 µg/mL; 72 h) maintains high cell viability (above 85%) in HepG2 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 19368-18-4
-
Appearance Solid
-
Masse moléculaire 269.30
-
Formule C16H15NO3
-
Color White to off-white
-
SMILES
O=C(O)C1=CC=CC=C1C(NC2=C(C)C=CC=C2C)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Int J Biol Macromol
Reticuline isomerase AKR1B1 with aldo-keto reductase activity and detoxification function from the insect Blaps rhynchopetera. [Abstract]2026 Mar:352:151224. PMID: 41791543
Solvant et solubilité
In Vitro:
DMSO : ≥ 40 mg/mL (148.53 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocole
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Pureté et documentation
-
Fiche technique (290 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.7133 mL | 18.5667 mL | 37.1333 mL | 92.8333 mL |
| 5 mM | 0.7427 mL | 3.7133 mL | 7.4267 mL | 18.5667 mL | |
| 10 mM | 0.3713 mL | 1.8567 mL | 3.7133 mL | 9.2833 mL | |
| 15 mM | 0.2476 mL | 1.2378 mL | 2.4756 mL | 6.1889 mL | |
| 20 mM | 0.1857 mL | 0.9283 mL | 1.8567 mL | 4.6417 mL | |
| 25 mM | 0.1485 mL | 0.7427 mL | 1.4853 mL | 3.7133 mL | |
| 30 mM | 0.1238 mL | 0.6189 mL | 1.2378 mL | 3.0944 mL | |
| 40 mM | 0.0928 mL | 0.4642 mL | 0.9283 mL | 2.3208 mL | |
| 50 mM | 0.0743 mL | 0.3713 mL | 0.7427 mL | 1.8567 mL | |
| 60 mM | 0.0619 mL | 0.3094 mL | 0.6189 mL | 1.5472 mL | |
| 80 mM | 0.0464 mL | 0.2321 mL | 0.4642 mL | 1.1604 mL | |
| 100 mM | 0.0371 mL | 0.1857 mL | 0.3713 mL | 0.9283 mL |
Ftaxilide Related Classifications
HY-B1040 Related Classifications
Powered by Bioz